Cite

HARVARD Citation

    Wang, X. et al. (2020). An open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202). Therapeutic advances in medical oncology. p. . [Online]. 
  
Back to record